Home
Biogen BIIB spent $1.7M on lobbying in Q2 2024 · Health Issues, Medicare and 4 more issues
Trade details
- Type
- Lobbying report
- Amount
- $1,670,000
- Quarter
- Q2 2024
- Stock
- Biogen BIIB
- Client
- Biogen
- Reported
- 24/07/22
Up 57.5% from last quarter
What else happened in Biogen around then
Filed or reported within 30 days of the trade day · 24/05/31~24/07/30Biogen's other lobbying reports
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$1.1M
$1.1M
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$60K
$60K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 04/20
for Q1